We show a highly differential and unexpected role for CaSR in the progression of MLL-AF9+ (and MN1+) AML versus BCR-ABL1+ CML and B-ALL. The gene discussed is CASR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.